| Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors M Yi, D Jiao, H Xu, Q Liu, W Zhao, X Han, K Wu Molecular cancer 17, 1-14, 2018 | 693 | 2018 |
| The CXCL8-CXCR1/2 pathways in cancer Q Liu, A Li, Y Tian, JD Wu, Y Liu, T Li, Y Chen, X Han, K Wu Cytokine & growth factor reviews 31, 61-71, 2016 | 586 | 2016 |
| Chimeric antigen receptor T cells: a novel therapy for solid tumors S Yu, A Li, Q Liu, T Li, X Yuan, X Han, K Wu Journal of hematology & oncology 10, 1-13, 2017 | 314 | 2017 |
| Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer Z Liu, L Liu, S Weng, C Guo, Q Dang, H Xu, L Wang, T Lu, Y Zhang, Z Sun, ... Nature communications 13 (1), 816, 2022 | 285 | 2022 |
| Down-regulation of Lncrna MALAT1 attenuates neuronal cell death through suppressing Beclin1-dependent autophagy by regulating Mir-30a in cerebral ischemic stroke D Guo, J Ma, L Yan, T Li, Z Li, X Han, S Shui Cellular Physiology and Biochemistry 43 (1), 182-194, 2017 | 185 | 2017 |
| Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells KW Ren, YH Li, G Wu, JZ Ren, HB Lu, ZM Li, XW Han International journal of oncology 50 (4), 1299-1311, 2017 | 150 | 2017 |
| Recent advances of bispecific antibodies in solid tumors S Yu, A Li, Q Liu, X Yuan, H Xu, D Jiao, RG Pestell, X Han, K Wu Journal of hematology & oncology 10, 1-16, 2017 | 142 | 2017 |
| Immunosenescence: molecular mechanisms and diseases Z Liu, Q Liang, Y Ren, C Guo, X Ge, L Wang, Q Cheng, P Luo, Y Zhang, ... Signal transduction and targeted therapy 8 (1), 200, 2023 | 136 | 2023 |
| Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma J Ma, T Li, X Han, H Yuan Journal of cancer research and clinical oncology 144, 205-214, 2018 | 126 | 2018 |
| High performance loose nanofiltration membranes obtained by a catechol-based route for efficient dye/salt separation J Wang, R He, X Han, D Jiao, J Zhu, F Lai, X Liu, J Liu, Y Zhang, ... Chemical Engineering Journal 375, 121982, 2019 | 125 | 2019 |
| Long non‐coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR‐152 Z Li, Y Li, Y Li, K Ren, X Li, X Han, J Wang Journal of Biochemical and Molecular Toxicology 31 (9), e21933, 2017 | 117 | 2017 |
| Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells K Ren, W Zhang, G Wu, J Ren, H Lu, Z Li, X Han Biomedicine & Pharmacotherapy 84, 1748-1759, 2016 | 100 | 2016 |
| Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment S Yu, Q Liu, X Han, S Qin, W Zhao, A Li, K Wu Experimental hematology & oncology 6, 1-15, 2017 | 97 | 2017 |
| Caesarean section combined with temporary aortic balloon occlusion followed by uterine artery embolisation for the management of placenta accreta XH Duan, YL Wang, XW Han, ZM Chen, QJ Chu, L Wang, DD Hai Clinical radiology 70 (9), 932-937, 2015 | 94 | 2015 |
| Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer Z Liu, CG Guo, Q Dang, L Wang, L Liu, S Weng, H Xu, T Lu, Z Sun, X Han EBioMedicine 75, 2022 | 87 | 2022 |
| DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis Q Liu, A Li, S Yu, S Qin, N Han, RG Pestell, X Han, K Wu Journal of hematology & oncology 11, 1-16, 2018 | 81 | 2018 |
| A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma Z Liu, Y Zhang, C Shi, X Zhou, K Xu, D Jiao, Z Sun, X Han Journal of Translational Medicine 19, 1-17, 2021 | 78 | 2021 |
| Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment Q Liu, S Yu, A Li, H Xu, X Han, K Wu Tumor Biology 39 (6), 1010428317712445, 2017 | 78 | 2017 |
| Long noncoding RNA HOTAIR controls cell cycle by functioning as a competing endogenous RNA in esophageal squamous cell carcinoma K Ren, Y Li, H Lu, Z Li, Z Li, K Wu, Z Li, X Han Translational oncology 9 (6), 489-497, 2016 | 78 | 2016 |
| LncRNA MALAT1 promotes tumor growth and metastasis by targeting miR-124/foxq1 in bladder transitional cell carcinoma (BTCC) D Jiao, Z Li, M Zhu, Y Wang, G Wu, X Han American journal of cancer research 8 (4), 748, 2018 | 74 | 2018 |
